Yujin Kang
MS Candidate (2021, 03 ~ 2023, 02)
Current: (주) 엔지노믹스
Kang, Y., Yeo, M., Choi, H., Jun, H., Eom, S., Park, S. G., Yoon, H., Kim, E.,* and Kang, S.* Lactate Oxidase/vSIRPa Conjugates Efficiently Consume Tumor-produced Lactate and Locally Produce Tumor-necrotic H2O2 to Suppress Tumor Growth. Int. J. Biol. Macromol., 2023, 231, 123577.
Choi, H.,# Yeo, M.,# Kang, Y.,# Kim, H. J., Park, S. G., Jang, E., Park, S. H.,* Kim, E.,* and Kang, S.* Lactate Oxidase/Catalase-displaying Nanoparticles Efficiently Consume Lactate in the Tumor Microenvironment to Effectively Suppress Tumor Growth. J. Nanobiotechnology, 2023, 21, 5.
(#: equally contributed)